Cargando…

Editorial on “Cell Therapy, Bispecific Antibodies and Other Immunotherapies against Cancer”

Detalles Bibliográficos
Autor principal: Golubovskaya, Vita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605091/
https://www.ncbi.nlm.nih.gov/pubmed/37894420
http://dx.doi.org/10.3390/cancers15205053
_version_ 1785126990460747776
author Golubovskaya, Vita
author_facet Golubovskaya, Vita
author_sort Golubovskaya, Vita
collection PubMed
description
format Online
Article
Text
id pubmed-10605091
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106050912023-10-28 Editorial on “Cell Therapy, Bispecific Antibodies and Other Immunotherapies against Cancer” Golubovskaya, Vita Cancers (Basel) Editorial MDPI 2023-10-19 /pmc/articles/PMC10605091/ /pubmed/37894420 http://dx.doi.org/10.3390/cancers15205053 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Golubovskaya, Vita
Editorial on “Cell Therapy, Bispecific Antibodies and Other Immunotherapies against Cancer”
title Editorial on “Cell Therapy, Bispecific Antibodies and Other Immunotherapies against Cancer”
title_full Editorial on “Cell Therapy, Bispecific Antibodies and Other Immunotherapies against Cancer”
title_fullStr Editorial on “Cell Therapy, Bispecific Antibodies and Other Immunotherapies against Cancer”
title_full_unstemmed Editorial on “Cell Therapy, Bispecific Antibodies and Other Immunotherapies against Cancer”
title_short Editorial on “Cell Therapy, Bispecific Antibodies and Other Immunotherapies against Cancer”
title_sort editorial on “cell therapy, bispecific antibodies and other immunotherapies against cancer”
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605091/
https://www.ncbi.nlm.nih.gov/pubmed/37894420
http://dx.doi.org/10.3390/cancers15205053
work_keys_str_mv AT golubovskayavita editorialoncelltherapybispecificantibodiesandotherimmunotherapiesagainstcancer